Nefopam Hydrochloride Ria Generics (Nefopam Hydrochloride)

Nefopam Hydrochloride is used to treat pain conditions that involve central nervous system pathways.

• Moderate acute pain: provides analgesia for pain of moderate intensity when non‑opioid treatment is required.
• Post‑operative pain: reduces pain following surgical procedures, facilitating patient recovery.
• Musculoskeletal pain: alleviates pain associated with musculoskeletal injuries or inflammation.

• Nefopam Hydrochloride produces central analgesia by simultaneously inhibiting the reuptake of the monoamines norepinephrine, serotonin and dopamine, thereby enhancing descending inhibitory pathways. In addition, it blocks voltage‑sensitive sodium channels on neuronal membranes, which diminishes neuronal excitability. These actions collectively contribute to effective relief of moderate intensity pain while preserving respiratory function.

Nefopam Hydrochloride may be associated with several adverse reactions, which are categorized by frequency and severity.

Common Side Effects

• Nausea: mild to moderate nausea may occur, often transient.
• Dry mouth: reduced salivation leading to a dry sensation in the mouth.
• Sweating: increased perspiration, especially in warm environments or during activity.
• Dizziness: transient light‑headedness or vertigo that usually resolves.

Serious or Rare Side Effects

• Tachycardia: rapid heart rate that may require medical assessment and monitoring.
• Seizures: rare occurrence of convulsive episodes, necessitating immediate care.
• Severe hypotension: marked drop in blood pressure that can cause fainting.

When prescribing Nefopam Hydrochloride, clinicians should consider several precautionary measures to ensure patient safety.

• Cardiovascular assessment: evaluate heart rate and blood pressure before initiating therapy.
• History of seizures: avoid use in patients with uncontrolled epilepsy or seizure disorders.
• Concomitant antidepressants: review use of MAO inhibitors or SSRIs due to additive serotonergic effects.
• Renal or hepatic impairment: adjust monitoring in patients with significant organ dysfunction.
• Pregnancy and lactation: use only if potential benefit justifies potential risk, as safety data are limited.
• Store at ambient temperature: keep below 25°C in the original packaging, protect from moisture.

Nefopam Hydrochloride can interact with other medicines; awareness of major and moderate interactions helps prevent adverse outcomes.

Major Interactions (Avoid)

• MAO inhibitors: concurrent use may precipitate severe hypertension or serotonin syndrome.
• SSRIs or SNRIs: combined serotonergic activity increases risk of serotonin syndrome.
• Tricyclic antidepressants: additive anticholinergic and cardiovascular effects.

Moderate Interactions (Monitor Closely)

• Antihypertensive agents: nefopam may enhance hypotensive effects, requiring blood pressure monitoring.
• Antiplatelet or anticoagulant drugs: potential for increased bleeding tendency.
• CYP450 substrates: nefopam may alter metabolism of drugs processed by CYP3A4, necessitating dose adjustments.